Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 41
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Infant Gut Microbiota Associated with Fine Motor Skills

  • Acuña, Inmaculada
  • Cerdo, Tomas
  • Ruiz, Alicia
  • Torres-Espínola, Francisco J
  • López-Moreno, Ana
  • Aguilera, Margarita
  • Suárez, Antonio
  • Campoy, Cristina
Background: During early life, dynamic gut colonization and brain development co-occur with potential cross-talk mechanisms affecting behaviour. Methods: We used 16S rRNA gene sequencing to examine the associations between gut microbiota and neurodevelopmental outcomes assessed by the Bayley Scales of Infant Development III in 71 full-term healthy infants at 18 months of age. We hypothesized that children would differ in gut microbial diversity, enterotypes obtained by Dirichlet multinomial mixture analysis and specific taxa based on their behavioural characteristics. Results: In children dichotomized by behavioural trait performance in above- and below-median groups, weighted Unifrac b-diversity exhibited significant differences in fine motor (FM) activity. Dirichlet multinomial mixture modelling identified two enterotypes strongly associated with FM outcomes. When controlling for maternal pre-gestational BMI and breastfeeding for up to 3 months, the examination of signature taxa in FM groups showed that Turicibacter and Parabacteroides were highly abundant in the below-median FM group, while Collinsella, Coprococcus, Enterococcus, Fusobacterium, Holdemanella, Propionibacterium, Roseburia, Veillonella, an unassigned genus within Veillonellaceae and, interestingly, probiotic Bifidobacterium and Lactobacillus were more abundant in the above-median FM group. Conclusions: Our results suggest an association between enterotypes and specific genera with FM activity and may represent an opportunity for probiotic interventions relevant to treatment for motor disorders.
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Maternal weight, gut microbiota, and the association with early childhood behavior: the PREOBE follow-up study

  • Nieto Ruiz, Ana María
  • Jordano, Belen
  • Escudero Marín, Mireia
  • García Ricobaraza, María
  • García Bermúdez, María Mercedes
  • García Santos, José Antonio
  • Suárez García, Antonio Francisco|||0000-0002-1006-7490
  • Campoy Folgoso, Cristina
Background and aim Maternal overweight and breastfeeding seem to have a significant impact on the gut microbiota colonization process, which co-occurs simultaneously with brain development and the establishment of the “microbiota-gut-brain axis”, which potentially may affect behavior later in life. This study aimed to examine the influence of maternal overweight, obesity and/or gestational diabetes on the offspring behavior at 3.5 years of age and its association with the gut microbiota already established at 18 months of life. Methods 156 children born to overweight (OV, n = 45), obese (OB, n = 40) and normoweight (NW, n = 71) pregnant women participating in the PREOBE study were included in the current analysis. Stool samples were collected at 18 months of life and gut microbiome was obtained by 16S rRNA gene sequencing. Behavioral problems were evaluated at 3.5 years by using the Child Behavior Checklist (CBCL). ANOVA, Chi-Square Test, ANCOVA, Spearman’s correlation, logistic regression model and generalized linear model (GLM) were performed. Results At 3.5 years of age, Children born to OV/OB mothers showed higher scores in behavioral problems than those born to NW mothers. Additionally, offspring born to OB mothers who developed gestational diabetes mellitus (GDM) presented higher scores in attention/deficit hyperactivity and externalizing problems than those born to GDM OV/NW mothers. Fusicatenibacter abundance found at 18 months of age was associated to lower scores in total, internalizing and pervasive developmental problems, while an unidentified genus within Clostridiales and Flavonifractor families abundance showed a positive correlation with anxiety/depression and somatic complaints, respectively. On the other hand, children born to mothers with higher BMI who were breastfed presented elevated anxiety, internalizing problems, externalizing problems and total problems scores; likewise, their gut microbiota composition at 18 months of age showed positive correlation with behavioral problems at 3.5 years: Actinobacteria abundance and somatic complaints and between Fusobacteria abundance and withdrawn behavior and pervasive developmental problems. Conclusions Our findings suggests that OV/OB and/or GDM during pregnancy is associated with higher behavioral problems scores in children at 3.5 years old. Additionally, associations between early life gut microbiota composition and later mental health in children was also found., Andalusian Government, Economy, Science and Innovation Ministry P06-CTS-02341, Spanish Government SB2010-0025, EU Project FP7 MyNewGut KBBE-2013-7 613979, Ministry of Economic Transformation, Industry, Knowledge, and University of the Junta de Andalucia (Andalusian Plan for Research, Development and Innovation, PAIDI 2020), Institute of Health Carlos III (ISCIII) CD21/00187
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

The Glycolitic Versatility of Bacteroides Uniformis CECT 7771 and and Its Genome Response to Oligo and Polysaccharides.

  • Benítez-Páez, Alfonso
  • Gómez Del Pulgar, Eva M.
  • Sanz, Yolanda
[EN] Bacteroides spp. are dominant components of the phylum Bacteroidetes in the gut microbiota and prosper in glycan enriched environments. However, knowledge of the machinery of specific species isolated from humans (like Bacteroides uniformis) contributing to the utilization of dietary and endogenous sources of glycans and their byproducts is limited. We have used the cutting-edge nanopore-based technology to sequence the genome of B. uniformis CECT 7771, a human symbiont with a proven pre-clinical efficacy on metabolic and immune dysfunctions in obesity animal models. We have also used massive sequencing approaches to distinguish the genome expression patterns in response to carbon sources of different complexity during growth. At genome-wide level, our analyses globally demonstrate that B. uniformis strains exhibit an expanded glycolytic capability when compared with other Bacteroides species. Moreover, by studying the growth and whole-genome expression of B. uniformis CECT 7771 in response to different carbon sources, we detected a differential growth fitness and expression patterns across the genome depending on the carbon source of the culture media. The dietary fibers used exerted different effects on B. uniformis CECT 7771 activating different molecular pathways and, therefore, allowing the production of different metabolite types with potential impact on gut health. The genome and transcriptome analysis of B. uniformis CECT 7771, in response to different carbon sources, shows its high versatility to utilize both dietary and endogenous glycans along with the production of potentially beneficial end products for both the bacterium and the host, pointing to a mechanistic basis of a mutualistic relationship., This study was supported by grants RTC-2016-5396-1 from the Spanish Ministry of Economy and Competitiveness (MINECO, Spain). The contract to ABP is supported by the EU Project MyNewGut (No. 613979) from the 7th Framework Program. Authors also thank to Joan Vermeiren and to Cargill R&D Centre Europe for the kind donation of WBE fiber for experiments.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Descifrando las funciones de la microbiota intestinal en la obesidad.

  • López Almela, Inmaculada
[ES] La obesidad es uno de los principales problemas de salud pública debido a su elevada prevalencia y a las comorbilidades asociadas, lo que se traduce en una reducción considerable de la calidad y esperanza de vida, además de un enorme gasto económico. Su origen es multifactorial y el desarrollo de terapias efectivas para combatirla resulta complejo. La microbiota intestinal ejerce un papel relevante en el mantenimiento del balance energético y salud metabólica. Por ello, las estrategias basadas en la modificación de la microbiota intestinal son consideradas potenciales alternativas para el manejo clínico de la obesidad. No obstante, se requiere un mayor conocimiento sobre cuáles son las especies bacterianas clave en el mantenimiento de la homeostasis energética del hospedador y su modo de acción. El objetivo general de la tesis ha sido identificar nuevas estrategias basadas en la manipulación de la composición y funciones de la microbiota intestinal eficaces contra la obesidad, así como sus mecanismos de interacción con el hospedador. El capítulo primero de la tesis se centra en estudiar los mecanismos de acción por los que Bacteroides uniformis CECT 7771 ejerce efectos protectores frente al desarrollo de la obesidad, tal y como nuestro grupo ha descrito en trabajos previos. A través de un estudio en ratones con obesidad inducida por la dieta hemos demostrado que esta cepa reduce la disfunción metabólica a través de la modulación de la microbiota intestinal y las alteraciones inmunológicas en el intestino y el tejido adiposo asociados a la obesidad. Todos los efectos sobre el eje intestino-tejido adiposo parecen estar mediados por la activación de TLR5. Además, hemos desarrollado una estrategia similar a un simbiótico con el fin de incrementar la eficacia de esta bacteria administrándola a dosis menores. La formulación simbiótica se diseñó en base a la preferencia de B. uniformis CECT 7771 por el salvado de trigo (WBE) como fuente de carbono en cultivos in vitro. La administración conjunta de la bacteria y WBE mostró beneficios inmuno-metabólicos al reducir el aumento de peso corporal y la adiposidad, al tiempo que mejoraron las rutas del metabolismo energético moduladas por insulina y la homeostasis inmunológica intestinal. Además, reforzó la primera línea de defensa inmunológica al aumentar los niveles de butirato y restaurar los niveles de IEL inducidos y las ILC3. En el segundo capítulo hemos llevado a cabo dos estudios preclínicos que describen los efectos de dos nuevas bacterias autóctonas del tracto gastrointestinal humano como potenciales probióticos para el tratamiento de la obesidad identificadas por el grupo. El primer estudio, la administración de Holdemanella biformis CECT 9752 a ratones con obesidad inducida por la dieta redujo los niveles de glucosa en ayuno y mejoró la tolerancia oral a la glucosa de forma independiente a la insulina. A nivel del contenido luminal del intestino grueso, la bacteria incrementó los niveles de ácidos grasos insaturados, potenciales secretagogos lipídicos de GLP-1. A nivel del intestino delgado, incrementó la sensibilidad a GLP-1 de las neuronas vagales aferentes, mecanismo implicado en la producción endógena de glucosa. A nivel hepático, la suplementación con la bacteria redujo la gluconeogénesis y mejoró la sensibilidad a insulina. En el segundo estudio hemos evaluado los efectos inmuno-metabólicos de Phascolarctobacterium faecium DSM 32890, consumidora de succinato y productora de propionato en un modelo animal de obesidad. La administración redujo el aumento de peso corporal y la ingesta de alimentos y mejoró la tolerancia oral a la glucosa. Estos beneficios se asociaron a un aumento sostenido de la hormona intestinal anorexigénica PYY en plasma y una prevención de la hipersecreción de GIP inducida por la dieta rica en grasa. Además, la bacteria normalizó la inmunidad intestinal alterada en la obesidad, y mejoró, [CA] L'obesitat és un dels principals problemas de salut pública a causa de la seua elevada prevalença i a les comorbilitats associades, la qual cosa es tradueix en una reducció considerable de la qualitat i de l'esperança de vida, a més d'una enorme despesa econòmica. El seu origen es multifactorial i el desenvolupament de teràpies efectives per combatre-les resulta complex. La microbiota intestinal exerceix un paper rellevant en el manteniment del balanç energètic i salut metabòlica. Per això, les estrategias basades en la modificació de la microbiota intestinal son considerades hui en dia potencials alternatives per al maneig clínic de l'obesitat. No obstant això, es requereix d'un major coneixement sobre quines son les espècies bacterianes claus al manteniment de l'homeòstasi energètica de l'hoste i la seua manera d'acció. L'objectiu general de la tesi ha sigut identificar noves estratègies basades en la manipulació de la composició i funcions de la microbiota intestinal eficaces contra l'obesitat, així com els seus mecanismes d'interacció amb l'hoste. El capítol primer de la tesi es centra en estudiar els mecanismes d'acció pels quals Bacteroides uniformis CECT 7771 exerceix efectes protectors enfront del desenvolupament de l'obesitat, tal com el nostre grup ha descrit previament. A través d'un estudi en ratolins amb obesitat induïda per la dieta hem demostrat que aquesta soca redueix la disfunció metabòlica a través de la modulació de la microbiota intestinal i les alteracions immunològiques en l'intestí i al teixit adipos epididimal associats a l'obesitat. Tots els efectes sobre l'eix intestí-teixit adipós semblen estar mediades per l'activació de TLR5. A més, hem desenvolupat una estrategia similar a un simbiòtic amb la finalitat d'incrementar l'eficàcia d'aquest bacteri administrant-la a dosis menors. La fomulació simbiòtica es va dissenyar basant-se en la preferència de B. uniformis CECT 7771 pel segó del blat (WBE) com a font de carboni en cultius in vitro. L'administració conjunta de la bacteria i WBE va mostrar beneficis immuno-metabòlics al reduir l'augment de pes corporal i l'adipositat, al mateix temps que van millorar les rutes del metabolisme energètic modulades per insulina i la homeòstasi immunològica intestinal. A més, va reforçar la primera línia de defensa immunològica augmentant els nivells de butirat i restaurant els nivells de IEL induïts i de ILC3. Al segon capítol de la tesi hem dut a terme dos estudis preclínics que descriuen els efectes de dos nous bacteris autòctones del tracte gastrointestinal humà com a potencials probiòtics per al tractament de l'obesitat identificades amb posterioritat pel grup. El primer estudi, l'administració de Holdemanella biformis CECT 9752 a un model animal d'obesitat va reduir els nivells de glucosa en dejú i va millorar la tolerància oral a la glucosa de manera independent a la insulina. A nivell del contingut luminal de l'intestí gros, el bacteri va incrementar els nivells d'àcids grassos insaturats, potencials secretagogos lipídics de GLP-1. A nivell de l'intestí prim, va incrementar la sensibilitat a GLP-1 de les neurones vagals aferents, mecanisme implicat en la producció endògena de glucosa. A nivell hepàtic, la suplementació amb el bacteri va reduir la gluconeogènesi i va millorar la sensibilitat a insulina. En el segon estudi hem avaluat els efectes immuno-metabòlics de Phascolarctobacterium faecium DSM 32890, consumidora de succinat i productora de propionat a un model animal d'obesitat. L'administració va reduir l'augment de pes corporal i l'ingesta d'aliments i va millorar la tolerància oral a la glucosa. Aquests beneficis es van associar a un augment sostingut de l'hormona intestinal anorexigénica PYY en plasma i la prevenció de la hipersecreció de GIP induïda per la dieta rica en greix. A més, el bacteri va normalitzar la immunitat intestinal alterada en l'obesitat i va millorar, [EN] Obesity is one of the main public health problems due to its high prevalence and associated comorbidities, which results in a considerable reduction of the health-related quality of life and life expectancy, as well as in an overwhelming cost to global health economies. It has a multifactorial origin and the development of effective therapies is complex and has become one of the main challenges for society. The gut microbiota plays an important role in the maintenance of energy balance and metabolic health. Therefore, strategies based on gut microbiota modification to beneficially modulate energy metabolism are nowadays considered potential alternatives for the clinical management of obesity. However, the effective implementation of these strategies requires the identification of key bacterial species for the maintenance of host energy homeostasis as well as the better understanding of which mechanisms are behind of their effects. The general objective of this doctoral thesis has been to identify new and effective strategies against obesity based on the manipulation of the gut microbiota composition and function, as well as their mechanisms of interaction with the host. The first chapter of the thesis focuses on studying the mechanisms of action by which Bacteroides uniformis CECT 7771 induces protective effects against the onset of obesity, based on previous studies of our group. An intervention conducted in diet-induced obese mice, we have demonstrated that this strain reduces metabolic dysfunction through the modulation of the intestinal microbiota and immune players obesity associated in both intestine and epididymal white adipose tissue. All the effects on the gut-adipose tissue axis appear to be mediated by TLR5 activation. Moreover, we have developed a symbiotic strategy with the aim of increasing the B. uniformis anti-obesity efficacy at lower doses. The symbiotic formulation was designed based on the preference of B. uniformis CECT 7771 for wheat bran (WBE) as a carbon source in in vitro cultures. The co-administration of the bacteria and WBE showed immuno-metabolic benefits reducing body weight gain and adiposity, along with improving insulin-modulated energy metabolism pathways and intestinal immune homeostasis. In addition, It strengthened the first line of immune defence by increasing butyrate levels and restoring levels of induced IEL and ILC3. In the second chapter of the thesis we have carried out two pre-clinical studies describing the effects of two new autochthonous bacteria of the human gastrointestinal tract as potential probiotics for the treatment of obesity identified later by the group. The first study, the administration of Holdemanella biformis CECT 9752 in an animal model obesity reduced fasting glucose levels and improved oral glucose tolerance in an insulin-independent manner. In the luminal content of the large intestine, the bacteria increased the abundance of unsaturated fatty acids, potential GLP-1 secretagogues. In the small intestine, it could directly increase the GLP-1 sensitivity of vagal afferent neurons, a mechanism involved in hepatic endogenous glucose production. At the hepatic level, the supplementation with the bacteria reduced gluconeogenesis and improved insulin sensitivity. In the second study we have evaluated the immuno-metabolic effects of Phascolarctobacterium faecium DSM 32890 succinate consumer and propionate producer in an animal model of diet-induced obesity. The bacteria reduced body weight gain and food intake and improved oral glucose tolerance. These benefits were associated with a sustained increase in plasma of the anorexigenic gut hormone PYY and a prevention of high-fat diet-induced GIP hypersecretion. In addition, the bacteria normalized the impaired intestinal immunity in obesity and improved intestinal barrier integrity., This study received funding from the European Union Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 797297 (M.R-P) and from the European Union 7th Framework program under the grant agreement no 613979 (MyNewGut) and grant AGL2017-88801-P from the Spanish Ministry of Economy and Competitiveness (MCIU, Spain). The Santiago Grisolía scholarship (GRISOLIAP/2014/110) to E.F from Generalitat Valenciana and the FPI scholarship (BES-2015-073930) of I López-Almela and the PTA contract (PTA2013-8836-I) of I. Campillo from MCIU are fully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Influence of gut-to-brain neuroendocrine pathways and intestinal microbiota on energy homeostasis

  • Bullich Vilarrubias, Clara
[ES] La obesidad es un gran reto de salud pública que ha alcanzado proporciones epidémicas. El entorno "occidentalizado" en el que vivimos, caracterizado por la accesibilidad a alimentos hipercalóricos, contribuye al desequilibrio crónico entre energía ingerida y gasto energético que causan la obesidad. Las intervenciones conductuales diseñadas para la pérdida de peso tienen limitada efectividad a largo plazo, por lo que existe una urgente necesidad de desarrollar estrategias más eficaces y seguras para prevenir y tratar la obesidad y sus comorbilidades. El desarrollo de estrategias terapéuticas dirigidas al intestino para mejorar la salud metabólica requiere un conocimiento en profundidad de las vías de señalización neuroendocrina intestinal que regulan el la ingesta y el equilibrio energético. El objetivo de esta tesis ha sido profundizar en las interacciones intestino-cerebro implicadas en el control de la homeostasis energética, incluyendo los componentes endocrinos, neurales y la microbiota intestinal, en el contexto del desarrollo de la obesidad inducida por una dieta hipercalórica. En los Capítulos 1 y 2 hemos explorado nuevas funciones de las neuronas sensoriales aferentes que expresan el canal de sodio Nav1.8 en el control de la homeostasis energética, considerando las diferencias entre sexos. Hemos generado un modelo de ratón carente de las neuronas Nav1.8+ mediante ablación con toxina diftérica. En el Capítulo 1 hemos demostrado que las neuronas Nav1.8+ son indispensables para regular específicamente según el sexo las vías neurales y endocrinas implicadas en la homeostasis energética. En hembras, la ablación de estas neuronas mejora la regulación de la glucosa postprandial potenciando la señalización enteroendocrina de GLP-1 y acelera el tránsito intestinal, mientras que en machos induce resistencia al aumento de peso inducido por una dieta obesogénica. En el Capítulo 2 hemos demostrado que, en machos, la ablación de las neuronas Nav1.8+ altera el control coordinado de la ingesta i las variaciones de peso diarias, además de alterar la señalización enteroendocrina y las oscilaciones diarias de la microbiota intestinal en respuesta al estado nutricional (ayuno/ingesta), y perturbar la homeostasis del sistema inmune intestinal. En el capítulo 3, hemos usado un modelo de ratón con obesidad inducida por dieta para explorar los mecanismos por los cuales Phascolarctobacterium faecium DSM 32890, una cepa bacteriana intestinal aislada de humanos metabólicamente sanos, previene la obesidad modulando la ingesta. La administración de P. faecium reduce la ingesta calórica gracias a la hipersecreción de la hormona gastrointestinal saciante el PYY. Independientemente de sus efectos anorexigénicos, la bacteria ejerce sus beneficios metabólicos estimulando el tránsito intestinal y reduciendo la absorción intestinal de lípidos, evitando la acumulación de grasa corporal. En conclusión, esta tesis doctoral proporciona evidencia preclínica que contribuye a una comprensión más precisa de las vías neuroendocrinas que comunican el intestino y el cerebro, y del papel que tiene la microbiota intestinal en la regulación de la ingesta y el gasto energético. Destacamos la importancia de las neuronas sensoriales aferentes Nav1.8+ en la detección de estímulos intestinales por quimiorreceptores para regular el balance energético en ambos sexos, lo cual abre una nueva línea de investigación para diseñar herramientas de neuromodulación de las neuronas Nav1.8+ con el fin de prevenir y tratar los trastornos metabólicos inducidos por la dieta, de forma específica para cada sexo. También destacamos que P. faecium es una bacteria candidata como probiótico de nueva generación, ya que modula el sistema enteroendocrino del hospedador y previene la obesidad en un modelo preclínico. En conjunto, estos hallazgos proporcionan una base para el desarrollo de estrategias terapéuticas basadas en el intestino dirigidas a combatir la obesidad y comorbilidades asociadas., [CA] L'obesitat és un gran repte de salut pública que ha assolit proporcions epidèmiques. L'entorn "occidentalitzat" en el que vivim, caracteritzat per l'accessibilitat a aliments hipercalòrics, contribueix al desequilibri crònic entre energia ingerida i despesa energètica que causen l'obesitat. Les intervencions conductuals dissenyades per a la pèrdua de pes tenen una eficàcia limitada a llarg termini, per la qual cosa hi ha una necessitat urgent de desenvolupar estratègies més eficaces i segures per a prevenir i tractar l'obesitat i les seues comorbiditats. El desenvolupament d'estratègies terapèutiques dirigides a l'intestí per a millorar la salut metabòlica requereix un coneixement en profunditat de les vies de senyalització neuroendocrina intestinal que regulen la ingesta i l'equilibri energètic. L'objectiu d'aquesta tesi ha sigut aprofundir en les interaccions intestí-cervell implicades en el control de l'homeòstasi energètica, incloent els components endocrins, neurals i la microbiota intestinal, en el context del desenvolupament de l'obesitat induïda per una dieta hipercalòrica. En els Capítols 1 i 2 hem explorat noves funcions de les neurones sensorials aferents que expressen el canal de sodi Nav1.8 en el control de l'homeòstasi energètica, considerant les diferències entre sexes. Hem generat un model de ratolí mancat de les neurones Nav1.8+ mitjançant ablació amb toxina diftèrica. En el Capítol 1 hem demostrat que les neurones Nav1.8+ són indispensables per a regular, específicament segons el sexe, les vies neurals i endocrines implicades en l'homeòstasi energètica. En femelles, l'ablació d'aquestes neurones millora la regulació de la glucosa postprandial potenciant la senyalització enteroendocrina de GLP-1 i accelera el trànsit intestinal, mentre que en mascles indueix resistència a l'augment de pes induït per una dieta obesogènica. En el Capítol 2 hem demostrat que, en mascles, l'ablació de les neurones Nav1.8+ altera el control coordinat de la ingesta i les variacions de pes diàries, a més d'alterar la senyalització enteroendocrina i les oscil·lacions diàries de la microbiota intestinal en resposta a l'estat nutricional (dejuni/ingesta), i pertorbar l'homeòstasi del sistema immunitari intestinal. En el capítol 3, hem utilitzat un model de ratolí amb obesitat induïda per dieta per explorar els mecanismes pels quals Phascolarctobacterium faecium DSM 32890, una soca bacteriana intestinal aïllada d'humans metabòlicament sans, prevé l'obesitat modulant la ingesta. L'administració de P. faecium redueix la ingesta calòrica gràcies a la hipersecreció de l'hormona gastrointestinal saciant PYY. Independentment dels seus efectes anorexigènics, el bacteri exerceix els seus beneficis metabòlics estimulant el trànsit intestinal i reduint l'absorció intestinal de lípids, evitant l'acumulació de greix corporal. En conclusió, aquesta tesi doctoral proporciona evidència preclínica que contribueix a una comprensió més precisa de les vies neuroendocrines que comuniquen l'intestí i el cervell, i del paper que té la microbiota intestinal en la regulació de la ingesta i la despesa energètica. Destaquem la importància de les neurones sensorials aferents Nav1.8+ en la detecció d'estímuls intestinals per quimioreceptors per a regular l'equilibri energètic en ambdós sexes, que obri una nova línia d'investigació per a dissenyar ferramentes de neuromodulació de les neurones Nav1.8+ amb la finalitat de prevenir i tractar els trastorns metabòlics induïts per la dieta, de forma específica per a cada sexe. També destaquem que P. faecium és un bacteri candidat com a probiòtic de nova generació, ja que modula el sistema enteroendocrí de l'hoste i prevé l'obesitat en un model preclínic. En conjunt, aquests troballes proporcionen una base per al desenvolupament d'estratègies terapèutiques basades en l'intestí dirigides a combatre l'obesitat i comorbiditats associades., [EN] Obesity is a major global public health challenge that has reached epidemic proportions. Besides its profound impact on health and well-being, this metabolic disorder represents a significant economic burden to society. Our westernized environment where high-calorie foods are readily available, represents a major driver of the chronic imbalance between energy intake and energy expenditure that cause obesity. The limited effectiveness of behavioral interventions to manage long-term weight loss highlights the urgent need to develop more effective and minimally invasive approaches to prevent and treat obesity and its comorbidities. The development of gut-targeted therapeutic strategies to improve metabolic health requires a comprehensive understanding of the gut neuroendocrine signaling pathways that, in interaction with the gut microbiota, control feeding behavior to ultimately maintain energy balance. The aim of this thesis has been to gain insight into gut-brain interactions, including those mediated by endocrine, neural and gut microbial components, involved in the control of energy homeostasis, with a focus on obesogenic diet-related dysfunctions that increase susceptibility to develop obesity. In Chapters 1 and 2, we have investigated novel functions of sensory afferent neurons expressing the sodium channel Nav1.8 in the control of energy homeostasis, considering sex-specificities, by generating a mouse model lacking Nav1.8+ neurons through a diphtheria toxin ablation strategy. In Chapter 1, we show that Nav1.8+ neurons are required to control neural and endocrine pathways involved in energy homeostasis in a sex-specific manner. Specifically, ablation of Nav1.8+ neurons in females improves postprandial glucose regulation by enhancing glucagon-like peptide-1 enteroendocrine signaling and accelerating intestinal transit, whereas in males it induces resistance to weight gain in response to an obesogenic diet. To further explore the role of Nav1.8+ neurons in controlling food intake and pre- and post-prandial daily rhythms that influence metabolic phenotype, in Chapter 2 we show in males that ablation of Nav1.8+ sensory neurons impairs the coordinated control of food intake and body weight fluctuations throughout the day. The loss of these neurons also alters the physiological enteroendocrine signaling and daily gut microbiota oscillations in response to the nutritional status (fasting/refeeding cycles) and disrupts intestinal immune homeostasis. In Chapter 3, we used a diet-induced obese mouse model to investigate the mechanisms by which Phascolarctobacterium faecium DSM 32890, a gut bacterial strain isolated from metabolically healthy humans, prevents obesity by modulating food intake. We show that administration of P. faecium reduces caloric intake by promoting hypersecretion of a satiating gastrointestinal hormone, the peptide YY (PYY). Independently of its anorexigenic effects, the bacterium exerts its metabolic benefits via complementary mechanisms, specifically by stimulating intestinal transit and reducing intestinal lipid absorption, thereby preventing body fat accumulation. In conclusion, this doctoral thesis provides preclinical evidence for a better understanding of gut-to-brain neuroendocrine pathways and the role of gut microbiota in the regulation of food intake and energy expenditure. We highlight the importance of Nav1.8+ sensory afferent neurons in gut chemosensing for maintaining energy balance in both sexes, which prompts novel research lines and opportunities to design of sex-specific neuromodulation tools targeting Nav1.8+ neurons for prevention and treatment of diet-induced metabolic disorders. We also highlight that P. faecium is a promising next-generation probiotic candidate, as it modulates the host enteroendocrine system and prevents obesity in a preclinical model. Overall, our findings contribute to the development of gut-based therapeutic strategies to combat obesity and associated comorbidities., This study has been funded by the European Union 7th Framework Program through the MyNewGut project (Grant agreement No. 613979) and Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 797297 (MRP), the Spanish Ministry of Science and Innovation (Grant PID2020-119536RB-I00), the European Commission – NextGenerationEU, through the CSIC Interdisciplinary Thematic Platform (PTI+) NEURO-AGING+ (PTI-NEURO-AGING+)”. The grant of the Spanish Ministry of Science and Innovation (MCIN/AEI) to IATA-CSIC as Accredited Center of Excellence (CEX2021-001189-S/ MCIN/AEI/10.13039/501100011033) is acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function

  • Agustí, Ana
  • García-Pardo, Maria P.
  • López-Almela, Inmaculada
  • Campillo, Isabel
  • Maes, Michael
  • Romaní-Pérez, Marina
  • Sanz, Yolanda
[EN] Obesity continues to be one of the major public health problems due to its high prevalence and co-morbidities. Common co-morbidities not only include cardiometabolic disorders but also mood and cognitive disorders. Obese subjects often show deficits in memory, learning and executive functions compared to normal weight subjects. Epidemiological studies also indicate that obesity is associated with a higher risk of developing depression and anxiety, and vice versa. These associations between pathologies that presumably have different etiologies suggest shared pathological mechanisms. Gut microbiota is a mediating factor between the environmental pressures (e.g., diet, lifestyle) and host physiology, and its alteration could partly explain the cross-link between those pathologies. Westernized dietary patterns are known to be a major cause of the obesity epidemic, which also promotes a dysbiotic drift in the gut microbiota; this, in turn, seems to contribute to obesity-related complications. Experimental studies in animal models and, to a lesser extent, in humans suggest that the obesity-associated microbiota may contribute to the endocrine, neurochemical and inflammatory alterations underlying obesity and its comorbidities. These include dysregulation of the HPA-axis with overproduction of glucocorticoids, alterations in levels of neuroactive metabolites (e.g., neurotransmitters, short-chain fatty acids) and activation of a pro-inflammatory milieu that can cause neuro-inflammation. This review updates current knowledge about the role and mode of action of the gut microbiota in the cross-link between energy metabolism, mood and cognitive function., This work and the contract of AA were supported by grant AGL2014-52101-P from the Spanish Ministry of Economy and Competitiveness (MINECO, Spain). The PTA contract of IC and the pre-doctoral scholarship of IL-A from MINECO (Spain) are also fully acknowledged. The contract of MR-P was supported by the EU Project MyNewGut (No. 613979) from the 7th Framework Program.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE)

  • Berglund, Staffan K.
  • García Valdés, Luz
  • Torres Espinola, Francisco José
  • Segura, Mª Teresa
  • Martínez Zaldívar, Cristina
  • Aguilar María, J.
  • Agil, Ahmad
  • Lorente Jose, A.
  • Florido, Jesús
  • Padilla, Carmen
  • Altmäe, Signe
  • Marcos, Ascensión
  • López Sabater, María del Carmen
  • Campoy Folgoso, Cristina
  • PREOBE Team
Abstract Background: Maternal overweight, obesity, and gestational diabetes (GD) have been negatively associated with offspring development. Further knowledge regarding metabolic and nutritional alterations in these mother and their offspring are warranted. Methods: In an observational cohort study we included 331 pregnant women from Granada, Spain. The mothers were categorized into four groups according to BMI and their GD status; overweight (n:56), obese (n:64), GD (n:79), and healthy normal weight controls (n:132). We assessed maternal growth and nutritional biomarkers at 24 weeks (n = 269), 34 weeks (n = 310) and at delivery (n = 310) and the perinatal characteristics including cord blood biomarkers. Results: Obese and GD mothers had significantly lower weight gain during pregnancy and infant birth weight, waist circumference, and placental weight were higher in the obese group, including a significantly increased prevalence of macrosomia. Except for differences in markers of glucose metabolism (glucose, HbA1c, insulin and uric acid) we found at some measures that overweight and/or obese mothers had lower levels of transferrin saturation, hemoglobin, Vitamin B12 and folate and higher levels of C-reactive protein, erythrocyte sedimentation rate, ferritin, and cortisol. GD mothers had similar differences in hemoglobin and C-reactive protein but higher levels of folate. The latter was seen also in cord blood. Conclusions: We identified several metabolic alterations in overweight, obese and GD mothers compared to controls. Together with the observed differences in infant anthropometrics, these may be important biomarkers in future research regarding the programming of health and disease in children. Trial registration: The trial was registered at clinicaltrials.gov, identifier (NCT01634464). Keywords: Pregnancy, Maternal overweight, Maternal obesity, Gestational diabetes, Offspring, Fetal nutrition, Early programming, Vitamin B12, Folate, Iron status, Glucose metabolism
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota, diet, and obesity-related disorders -The good, the bad, and the future challenges, Gut microbiota, diet, and obesity-related disorders - The good, the bad, and the future challenges

  • Portune, Kevin J.
  • Benítez-Páez, Alfonso
  • Gómez del Pulgar, Eva M.
  • Cerrudo, Víctor
  • Sanz Herranz, Yolanda
Diet has been shown to be a major factor in modulating the structure of the mammalian gut microbiota by providing specific nutrient sources and inducing environmental changes (pH, bile acids) in the gut ecosystem. Long-term dietary patterns and short-term interventions have been shown to induce changes in gut microbiota structure and function, with several studies revealing metabolic changes likely resulting from the host microbiota cross-talk, which ultimately could influence host physiology. However, a more precise identification of the specific dietary patterns and food constituents that effectively modulate the gut microbiota and bring a predictable benefit to the host metabolic phenotype is needed to establish microbiome-based dietary recommendations. Here, we briefly review the existing data regarding gut microbiota changes induced by different macronutrients and the resulting metabolites produced via their respective fermentation, including their potential effects on obesity and associated metabolic disorders. We also discuss major limitations of current dietary intervention studies as well as future needs of applying cutting-edge “omic” techniques and of progressing in functional microbiota gene discovery to establish robust causal relationships between the dietary microbiota induced changes and metabolic health or disease., This works is supported by the European Union’s Seventh Framework Program under the grant agreement no 613979 (MyNewGut) and grant AGL2014-52101-P from the Spanish Ministry of Economy and Competitiveness (MINECO, Spain). The FPU scholarship of V. Cerrudo from MECD (Spain) is fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota role in dietary protein metabolism and health-related outcomes: The two sides of the coin

  • Portune, Kevin J.
  • Beaumont, Martin
  • Davila, Anne-Marie
  • Tomé, Daniel
  • Blachier, François
  • Sanz Herranz, Yolanda
Background: Human gut bacteria can synthesize proteinogenic amino acids and produce a range of metabolites via protein fermentation, some known to exert beneficial or harmful physiological effects on the host. However, the effects of the type and amount of dietary protein consumed on these metabolic processes, as well as the effects of the microbiota-derived amino acids and related metabolites on the host health are still predominantly unknown. Scope and approach:This review provides an up-to-date description of the dominant pathways/genes involved in amino acid metabolism in gut bacteria, and provides an inventory of metabolic intermediates derived from bacterial protein fermentation that may affect human health. Advances in understanding bacterial protein fermentation pathways and metabolites generated at a global level via the implementation of ‘omics’ technologies are reviewed. Finally, the impact of dietary protein intake and high-protein diets on human health is discussed. Key findings and conclusions:The intestinal microbiota is able to synthesize amino acids, but the net result of amino acid production and utilization, according to dietary patterns still needs to be determined. The amount of ingested dietary protein appears to modify both the diversity and composition of the intestinal microbiota as well as the luminal environment of the intestinal epithelium and peripheral tissues. The understanding of the consequences of such changes on the host physiology and pathophysiology is still in an early stage but major progress is expected in the near future with the investigation of host-microbe omics profiles from well-controlled human intervention studies., This works is supported by the European Union's Seventh Framework Program under the grant agreement no 613979 (MyNewGut)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genome structure of the symbiont Bifidobacterium pseudocatenulatum CECT 7765 and gene expression profiling in response to lactulose-derived oligosaccharides

  • Benítez-Páez, Alfonso
  • Moreno, F. Javier
  • Sanz, M. Luz
  • Sanz Herranz, Yolanda
Bifidobacterium pseudocatenulatum CECT 7765 was isolated from stools of a breast-fed infant. Although, this strain is generally considered an adult-type bifidobacterial species, it has also been shown to have pre-clinical efficacy in obesity models. In order to understand the molecular basis of its adaptation to complex carbohydrates and improve its potential functionality, we have analyzed its genome and transcriptome, as well as its metabolic output when growing in galacto-oligosaccharides derived from lactulose (GOS-Lu) as carbon source. B. pseudocatenulatum CECT 7765 shows strain-specific genome regions, including a great diversity of sugar metabolic-related genes. A preliminary and exploratory transcriptome analysis suggests candidate over-expression of several genes coding for sugar transporters and permeases; furthermore, five out of seven beta-galactosidases identified in the genome could be activated in response to GOS-Lu exposure. Here, we also propose that a specific gene cluster is involved in controlling the import and hydrolysis of certain di- and tri-saccharides, which seemed to be those primarily taken-up by the bifidobacterial strain. This was discerned from mass spectrometry-based quantification of different saccharide fractions of culture supernatants. Our results confirm that the expression of genes involved in sugar transport and metabolism and in the synthesis of leucine, an amino acid with a key role in glucose and energy homeostasis, was up-regulated by GOS-Lu. This was done using qPCR in addition to the exploratory information derived from the single-replicated RNAseq approach, together with the functional annotation of genes predicted to be encoded in the B. pseudocatenulatum CETC 7765 genome., This study was supported by public grants AGL2011-27884 to FM and AGL2011-25169, and Consolider Fun-C-Food CSD2007-00063 to YS from the Spanish Ministry of Economy and Competitiveness (MINECO, Spain). The postdoctoral contract to AB-P was funded by AGL2011-25169 and the EU Project MyNewGut (no 613979) from the 7th Framework Program., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of dietary fiber and fat on gut microbiota re-modeling and metabolic health

  • Benítez-Páez, Alfonso
  • Gómez del Pulgar, Eva M.
  • Kjølbæk, Louise
  • Brahe, Lena Kirchner
  • Astrup, Arne
  • Larsen, LesliHingstrup
  • Sanz Herranz, Yolanda
Background: Scientific evidence suggests that diet plays a role in obesity and its comorbidities, partly via its interactions with the individual's gut microbiota. Likewise, the individual's microbiota influences the efficacy of dietary interventions to reduce body weight. However, we require a better understanding of the key components of the gut microbiota that are responsive to specific diets and of their effects on energy balance in order to use this information in practice. Scope and approach: This review provides an up-to-date description of the influence of dietary fibers and fat on gut microbiota and the mechanisms presumably mediating their effects on metabolic health. We also discuss the main knowledge gaps and the need to gain greater understanding of the role of diet-microbe interactions in obesity and the associated comorbidities. Key findings and conclusions: Dietary fibers are major drivers of gut microbiota composition and function, stimulating the dominance of bacteria able to utilize these substrates as energy source, although effects vary depending on both the type of fiber and the individual's microbiota. However, the key bacteria and the primary and secondary metabolic pathways mediating specific fiber-induced effects on the metabolic phenotype remain unclear, and this information is necessary to personalize fiber-based interventions. The literature also shows that gut microbiota contributes to the adverse consequences of high-fat diets on the metabolic phenotype; however, little is known about the effects of dietary fat type. Further progress is expected from translational approaches integrating controlled dietary intervention human trials, combining functional omics technologies and physiological/clinical endpoints, and mechanistic studies in experimental models. This will ultimately help us to progress towards establishing informed microbiome-based dietary recommendations and interventions, which can contribute to tackling the obesity epidemic and its comorbidities., This works was supported by the European Union's Seventh Framework Program under the grant agreement no 613979 (MyNewGut) and by FUNDACION MAPFRE under grant ″Hernando de Larramendi″ call 2014., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Safety Assessment of Bacteroides uniformis CECT 7771 Isolated from Stools of Healthy Breast-Fed Infants

  • Fernández-Murga, María Leonor
  • Sanz Herranz, Yolanda
Background: Bacteroides uniformis CECT 7771 is a potential probiotic strain, originally isolated from the stools of healthy breast-feed infants. The strain showed pre-clinical efficacy in a mouse obesity model. The objective of this study was to evaluate its potential toxicity and translocation ability after acute oral administration to mice. Methods and Findings: A safety study was conducted in immunocompetent and immunosuppressed C57BL-6 mice. Both mouse groups (n = 10 per group) were fed orally 2 x 109 colony forming units (cfu)/day of B. uniformis CECT 7771 or placebo by gavage for 6 days. Throughout this time, feed and water intake and body weight were monitored. Afterwards, mice were sacrificed and biological samples were collected to analyze blood and urine biochemistry, inflammatory and immune markers; gut mucosal histology and bacterial translocation to peripheral tissues. The results demonstrated that acute ingestion of this Bacteroides strain had no adverse effects on the animals’ general health status or food intake, nor did it affect biochemical indicators of liver, kidney and pancreatic function or gut mucosal histology. Findings also demonstrated that administration did not lead to bacterial translocation to blood, liver or mesenteric lymph nodes. B. uniformis CECT 7771 also downregulated gene and protein expression (iNOS and PPAR-γ) and inflammatory cytokines induced by immunosuppression. Conclusions: The findings indicate that the acute oral consumption of B. uniformis CECT 7771 does not raise safety concerns in mice. Further studies in humans should be conducted., This study was supported by the EU Project no 613979 (MyNewGut) from the 7th Framework Program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unpurified Gelidium-extracted carbohydrate-rich fractions improve probiotic protection during storage

  • Alehosseini, Ali
  • Gómez del Pulgar, Eva M.
  • Gómez-Mascaraque, Laura G.
  • Martínez Sanz, Marta
  • Fabra, María José
  • Sanz Herranz, Yolanda
  • Sarabi-Jamab, Mahboobe
  • Ghorani, Behrouz
  • López-Rubio, Amparo
The objective of this work was to investigate whether the use of unpurified agar-based fractions extracted from the seaweed Gelidium as microencapsulation matrices has an impact on probiotic protection during storage. Therefore, unpurified and pure agar and agarose-based microcapsules were produced through emulsification/internal gelation for the protection of Bifidobacterium pseudocatenulatum CECT 7765. Initially, agarose-based formulations with other biopolymers were evaluated, given the excellent oxygen barrier properties of this polysaccharide. The optimal combination in terms of probiotic protection was selected for further experiments and this agarose-based formulation was compared with microcapsules produced using both pure and unpurified agar-based fractions. The presence of other compounds (mainly proteins and polyphenols) in the unpurified agar fractions significantly improved the viability of these sensitive probiotic bacteria both at ambient and refrigerated storage conditions. Furthermore, the presence of impurities allowed the increase of solids content in the formulation giving raise to stronger gel particles, which could contribute to limited oxygen diffusion, thus, partly explaining the improved protection. Therefore, this work demonstrates the potential of more cost-effective less purified carbohydrate-based fractions for probiotic protection., This work was financially supported by the “Agencia Estatal de Investigación” and co-funded by the European Union's Horizon 2020 research and innovation programme (ERA-Net SUSFOOD2) and the European Union's Seventh Framework Program under the grant agreement no 613979 (MyNewGut). Marta Martinez-Sanz, Maria José Fabra and Laura G. Gómez-Mascaraque are recipients of a Juan de la Cierva (IJCI-2015-23389), Ramon y Cajal (RYC-2014-158) and predoctoral (BES-2013-065883) contracts, respectively, from the Spanish Ministry of Economy, Industry and Competitiveness., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Agarose-based freeze-dried capsules prepared by the oil-induced biphasic hydrogel particle formation approach for the protection of sensitive probiotic bacteria

  • Alehosseini, Ali
  • Gómez del Pulgar, Eva M.
  • Fabra, María José
  • Gómez-Mascaraque, Laura G.
  • Benítez-Páez, Alfonso
  • Sarabi-Jama, M.
  • Ghorani, B.
  • López-Rubio, Amparo
This work reports on a simple, fast and food-grade encapsulation approach with potential for probiotic protection, which consists on the formation of agarose-based hydrogel particles. These were generated by the supramolecular self-assembly of the probiotic-containing carbohydrate solutions by dripping them into a biphasic bath with an upper oil layer, which acted as the particle-forming antisolvent, and a lower aqueous layer, where the hydrogel particles were collected. This technique, which we have named “oil-induced biphasic hydrogel particle formation”, has been used to encapsulate the sensitive strain Bifidobacterium pseudocatenulatum CECT 7765. In order to avoid agarose gelling at 40 °C before the encapsulation process, this seaweed-derived carbohydrate was combined with other hydrocolloids (alginate, whey protein concentrate, and gelatin), and the obtained probiotic-containing hydrogel particles were subsequently freeze-dried. The protection ability of this method versus directly freeze-drying the probiotic-containing solutions was demonstrated during storage and simulated in-vitro digestion. Both the formation of a continuous layer surrounding the bacteria and the optimal combination of materials (agarose providing suitable oxygen barrier and WPC with proven probiotic affinity) rendered encapsulation systems keeping viability levels required for commercial applications., A. Alehosseini received a scholarship by the Ministry of Science, Research and Technology of Iran. M.J. Fabra is recipient of a Ramon y Cajal (RYC-2014-158) contract from the Spanish Ministry of Economy, Industry and Competitiveness. The authors would like to thank the Spanish MINECO project AGL2015-63855-C2-1 and the Agencia Estatal de Investigación for financial support. ABP and EMGP are contracted with the grant no 613979 of the European Union's Seventh Framework Program (MyNewGut)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study

  • Olivares, Marta
  • Benítez-Páez, Alfonso
  • Palma, Giada de
  • Capilla, Amalia
  • Nova, Esther
  • Castillejo, Gemma
  • Varea, Vicente
  • Marcos, Ascensión
  • Garrote, José Antonio
  • Polanco, Isabel
  • Donat, Ester
  • Ribes-Koninckx, Carmen
  • Calvo, Carmen
  • Ortigosa, Luis
  • Palau Martínez, Francesc
  • Sanz Herranz, Yolanda
8 páginas, 1 figura, 2 tablas, Celiac disease (CD) is an immune-mediated enteropathy involving genetic and environmental factors, whose interaction influences disease risk. The intestinal microbiota, including viruses and bacteria, could play a role in the pathological process leading to gluten intolerance. In this study, we investigated the prevalence of pathogens in the intestinal microbiota of infants at familial risk of developing CD. We included 127 full-term newborns with at least one first-degree relative with CD. Infants were classified according to milk-feeding practice (breastfeeding or formula feeding) and HLA-DQ genotype (low, intermediate or high genetic risk). The prevalence of pathogenic bacteria and viruses was assessed in the faeces of the infants at 7 days, 1 month and 4 months of age. The prevalence of Clostridium perfringens was higher in formula-fed infants than in breast-fed over the study period, and that of C. difficile at 4 months. Among breastfed infants, a higher prevalence of enterotoxigenic E. coli (ETEC) was found in infants with the highest genetic risk compared either to those with a low or intermediate risk. Among formula-fed infants, a higher prevalence of ETEC was also found in infants with a high genetic risk compared to those of intermediate risk. Our results show that specific factors, such as formula feeding and the HLA-DQ2 genotype, previously linked to a higher risk of developing CD, influence the presence of pathogenic bacteria differently in the intestinal microbiota in early life. Further studies are warranted to establish whether these associations are related to CD onset later in life., This work was supported by grants AGL2011-25169, AGL2014-52101-P and AGL2007-66126-C03-03/ALI (YS and FP) from the Spanish Ministry of Economy and Competitiveness (MINECO). The scholarship to MO from CSIC (JAEpre) and the contract to ABP from the European Union's Seventh Framework Program under the grant agreement no 613979 (MyNewGut) are also fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Species-level resolution of 16S rRNA gene amplicons sequenced through the MinION™ portable nanopore sequencer

  • Benítez-Páez, Alfonso
  • Portune, Kevin J.
  • Sanz Herranz, Yolanda
Background: The miniaturised and portable DNA sequencer MinION™ has been released to the scientific community within the framework of an early access programme to evaluate its application for a wide variety of genetic approaches. This technology has demonstrated great potential, especially in genome-wide analyses. In this study, we tested the ability of the MinION™ system to perform amplicon sequencing in order to design new approaches to study microbial diversity using nearly full-length 16S rDNA sequences. Results: Using R7.3 chemistry, we generated more than 3.8 million events (nt) during a single sequencing run. These data were sufficient to reconstruct more than 90 % of the 16S rRNA gene sequences for 20 different species present in a mock reference community. After read mapping and 16S rRNA gene assembly, consensus sequences and 2d reads were recovered to assign taxonomic classification down to the species level. Additionally, we were able to measure the relative abundance of all the species present in a mock community and detected a biased species distribution originating from the PCR reaction using 'universal' primers. Conclusions: Although nanopore-based sequencing produces reads with lower per-base accuracy compared with other platforms, the MinION™ DNA sequencer is valuable for both high taxonomic resolution and microbial diversity analysis. Improvements in nanopore chemistry, such as minimising base-calling errors and the nucleotide bias reported here for 16S amplicon sequencing, will further deliver more reliable information that is useful for the specific detection of microbial species and strains in complex ecosystems., Authors thank the European 7th Framework Programme for funding ABP and KP, who were supported by the EC Project no. 613979 (MyNewGut), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Towards microbiome-informed dietary recommendations for promoting metabolic and mental health: Opinion papers of the MyNewGut project

  • Sanz Herranz, Yolanda
  • Romaní Pérez, Marina
  • Benítez-Páez, Alfonso
  • Portune, Kevin J.
  • Brigidi, P.
  • Rampelli, S.
  • Dinan, T.
  • Stanton, C.
  • Delzenne, N.
  • Blachier, F.
  • Neyrinck, Audrey M.
  • Beaumont, M.
  • Olivares, Marta
  • Holzer, P.
  • Günther, K.
  • Wolters, M.
  • Ahrens, W.
  • Claus, Sandrine P.
  • Campoy, Cristina
  • Murphy, R.
  • Sadler, C.
  • Fernández, Laura
  • Kamp, J.W.
The gut microbiota coexists in partnership with the human host through adaptations to environmental and physiological changes that help maintain dynamic homeostatic healthy states. Break-down of this delicate balance under sustained exposure to stressors (e.g. unhealthy diets) can, however, contribute to the onset of disease. Diet is a key modifiable environmental factor that modulates the gut microbiota and its metabolic capacities that, in turn, could impact human physiology. On this basis, the diet and the gut microbiota could act as synergistic forces that provide resilience against disease or that speed the progress from health to disease states. Associations between unhealthy dietary patterns, non-communicable diseases and intestinal dysbiosis can be explained by this hypothesis. Translational studies showing that dietary-induced alterations in microbial communities recapitulate some of the pathological features of the original host further support this notion. In this introductory paper by the European project MyNewGut, we briefly summarize the investigations conducted to better understand the role of dietary patterns and food components in metabolic and mental health and the specificities of the microbiome-mediating mechanisms. We also discuss how advances in the understanding of the microbiome's role in dietary health effects can help to provide acceptable scientific grounds on which to base dietary advice for promoting healthy living., The MyNewGut project is financially supported by a grant within the EU 7th Framework Programme under Grant Agreement 613979. The EU is not liable for the content presented in this publication. MO is a beneficiary of a >MOVE-IN Louvain> (incoming Post-Doctoral Fellowship co-funded by the Marie Curie Actions of the European)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Multi-omics Approach to Unraveling the Microbiome-Mediated Effects of Arabinoxylan Oligosaccharides in Overweight Humans

  • Benítez-Páez, Alfonso
  • Kjølbæk, Louise
  • Gómez del Pulgar, Eva M.
  • Brahe, L.K.
  • Astrup, A.
  • Matysik, S.
  • Schött, H.F.
  • Krautbauer, S.
  • Liebisch, G.
  • Boberska, J.
  • Claus, S.
  • Rampelli, S.
  • Brigidi, P.
  • Larsen, L.H.
  • Sanz Herranz, Yolanda
Long-term consumption of dietary fiber is generally considered beneficial for weight management and metabolic health, but the results of interventions vary greatly depending on the type of dietary fibers involved. This study provides a comprehensive evaluation of the effects of a specific dietary fiber consisting of a wheat-bran extract enriched in arabinoxylan-oligosaccharides (AXOS) in a human intervention trial. An integrated multi-omics analysis has been carried out to evaluate the effects of an intervention trial with an AXOS-enriched diet in overweight individuals with indices of metabolic syndrome. Microbiome analyses were performed by shotgun DNA sequencing in feces; in-depth metabolomics using nuclear magnetic resonance in fecal, urine, and plasma samples; and massive lipid profiling using mass spectrometry in fecal and serum/plasma samples. In addition to their bifidogenic effect, we observed that AXOS boost the proportion of Prevotella species. Metagenome analysis showed increases in the presence of bacterial genes involved in vitamin/cofactor production, glycan metabolism, and neurotransmitter biosynthesis as a result of AXOS intake. Furthermore, lipidomics analysis revealed reductions in plasma ceramide levels. Finally, we observed associations between Prevotella abundance and short-chain fatty acids (SCFAs) and succinate concentration in feces and identified a potential protective role of Eubacterium rectale against metabolic disease given that its abundance was positively associated with plasma phosphatidylcholine levels, thus hypothetically reducing bioavailability of choline for methylamine biosynthesis. The metagenomics, lipidomics, and metabolomics data integration indicates that sustained consumption of AXOS orchestrates a wide variety of changes in the gut microbiome and the host metabolism that collectively would impact on glucose homeostasis. (This study has been registered at ClinicalTrials.gov under identifier NCT02215343.) IMPORTANCE The use of dietary fiber food supplementation as a strategy to reduce the burden of diet-related diseases is a matter of study given its cost-effectiveness and the positive results demonstrated in clinical trials. This multi-omics assessment, on different biological samples of overweight subjects with signs of metabolic syndrome, sheds light on the early and less evident effects of short-term AXOS intake on intestinal microbiota and host metabolism. We observed a deep influence of AXOS on gut microbiota beyond their recognized bifidogenic effect by boosting concomitantly a wide diversity of butyrate producers and Prevotella copri, a microbial species abundant in non-Westernized populations with traditional lifestyle and diets enriched in fresh unprocessed foods. A comprehensive evaluation of hundreds of metabolites unveiled new benefits of the AXOS intake, such as reducing the plasma ceramide levels. Globally, we observed that multiple effects of AXOS consumption seem to converge in reversing the glucose homeostasis impairment., This study was supported by the EU Project MyNewGut (no. 613979) from the European Commission 7th Framework Program., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems

  • Flandroy, L.
  • Poutahidis, T.
  • Berg, Gabriele
  • Clarke, Gerard
  • Dao, M.C.
  • Decaestecker, E.
  • Furman, E.
  • Haahtela, T.
  • Massart, S.
  • Plovier, H.
  • Sanz Herranz, Yolanda
  • Rook, G.
Plants, animals and humans, are colonized by microorganisms (microbiota) and transiently exposed to countless others. The microbiota affects the development and function of essentially all organ systems, and contributes to adaptation and evolution, while protecting against pathogenic microorganisms and toxins. Genetics and lifestyle factors, including diet, antibiotics and other drugs, and exposure to the natural environment, affect the composition of the microbiota, which influences host health through modulation of interrelated physiological systems. These include immune system development and regulation, metabolic and endocrine pathways, brain function and epigenetic modification of the genome. Importantly, parental microbiotas have transgenerational impacts on the health of progeny. Humans, animals and plants share similar relationships with microbes. Research paradigms from humans and other mammals, amphibians, insects, planktonic crustaceans and plants demonstrate the influence of environmental microbial ecosystems on the microbiota and health of organisms, and indicate links between environmental and internal microbial diversity and good health. Therefore, overlapping compositions, and interconnected roles of microbes in human, animal and plant health should be considered within the broader context of terrestrial and aquatic microbial ecosystems that are challenged by the human lifestyle and by agricultural and industrial activities. Here, we propose research priorities and organizational, educational and administrative measures that will help to identify safe microbe-associated health-promoting modalities and practices. In the spirit of an expanding version of “One health” that includes environmental health and its relation to human cultures and habits (EcoHealth), we urge that the lifestyle-microbiota-human health nexus be taken into account in societal decision making., GC's attendance at the workshop was supported by the APC Microbiome Institute via Science Foundation Ireland funding (Grant number SFI/12/RC/2273). ED was supported by FWO grant G.0643.13. GB was funded by the European Union (BIOCOMES; 612713) and by the Austrian and Styrian Science Fund (FWF; P29285-BBL). M-CD received funding from the Programme for Research, Technological Development and Demonstration under grant agreement HEALTH-F4-2012-305312 (METACARDIS) and Horizon 2020 Framework Programme (EPoS, grant #634413) as well as Assistance Publique Hôpitaux de Paris. HP is a research fellow at FRS-FNRS, Belgium. The contribution of YS is supported by the European Union's Seventh Framework Program under the grant agreement no 613979 (MyNewGut)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Safety Assessment of Bacteroides Uniformis CECT 7771, a Symbiont of the Gut Microbiota in Infants

  • Gómez del Pulgar, Eva M.
  • Benítez-Páez, Alfonso
  • Sanz Herranz, Yolanda
© 2020 by the authors., The formulation of next-generation probiotics requires competent preclinical studies to show their efficacy and safety status. This study aims to confirm the safety of the prolonged oral use of Bacteroides uniformis CECT 7771, a strain that protected against metabolic disorders and obesity in preclinical trials, in a sub-chronic 90 day trial in animals. The safety assessment was conducted in male and female Wistar rats (n = 50) administered increasing doses (108 CFU/day, 109 CFU/day, or 1010 CFU/day) of B. uniformis CECT 7771, 1010 CFU/day of B. longum ATCC 15707T, which complies with the qualifying presumption of safety (QPS) status of the EU, or vehicle (placebo), as the control. Pancreatic, liver, and kidney functions and cytokine concentrations were analyzed. Bacterial translocation to peripheral tissues was evaluated, and colon integrity was investigated histologically. No adverse metabolic or tissue integrity alterations were associated with treatments; however, alanine aminotransferase levels and the ratio of anti-inflammatory to pro-inflammatory cytokines in serum indicated a potentially beneficial role of B. uniformis CECT 7771 at specific doses. Additionally, the microbial community structure was modified by the interventions, and potentially beneficial gut bacteria were increased. The results indicated that the oral consumption of B. uniformis CECT 7771 during a sub-chronic 90 day study in rats did not raise safety concerns., This study was fully supported by the EU Project MyNewGut (Grant agreement No. 613979) from the European Commission 7th Framework Program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nutritional interest of dietary fiber and prebiotics in obesity: Lessons from the MyNewGut consortium

  • Delzenne, N.M.
  • Olivares, Marta
  • Neyrinck, Audrey M.
  • Beaumont, M.
  • Kjølbæk, Louise
  • Larsen, T.M.
  • Benítez-Páez, Alfonso
  • Romaní Pérez, Marina
  • Garcia-Campayo, V.
  • Bosscher, D.
  • Sanz Herranz, Yolanda
  • van der Kamp, J.W.
The aim of EU project MyNewGut is to contribute to future public health-related recommendations supported by new insight in gut microbiome and nutrition-host relationship. In this Opinion Paper, we first revisit the concept of dietary fiber, taking into account their interaction with the gut microbiota. This paper also summarizes the main effects of dietary fibers with prebiotic properties in intervention studies in humans, with a particular emphasis on the effects of arabinoxylans and arabinoxylo-oligosaccharides on metabolic alterations associated with obesity. Based on the existing state of the art and future development, we elaborate the steps required to propose dietary guidelines related to dietary fibers, taking into account their interaction with the gut microbiota., The MyNewGut project is financially supported by a grant from the EU 7th Framework Program under Grant Agreement 613979. MO is a beneficiary of a “MOVE-IN Louvain” grant (incoming Post-Doctoral Fellowship co-funded by the Marie Curie Actions of the European Commission).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Depletion of Blautia Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening

  • Benítez-Páez, Alfonso
  • Gómez del Pulgar, Eva M.
  • López-Almela, Inmaculada
  • Moya Pérez, Ángela
  • Codoñer-Franch, Pilar
  • Sanz Herranz, Yolanda
Cross-sectional studies conducted with obese and control subjects have suggested associations between gut microbiota alterations and obesity, but the links with specific disease phenotypes and proofs of causality are still scarce. The present study aimed to profile the gut microbiota of lean and obese children with and without insulin resistance to characterize associations with specific obesity-related complications and understand the role played in metabolic inflammation. Through massive sequencing of 16S rRNA gene amplicons and data analysis using a novel permutation approach, we have detected decreased incidence of Blautia species, especially Blautia luti and B. wexlerae, in the gut microbiota of obese children, which was even more pronounced in cases with both obesity and insulin resistance. There was also a parallel increase in proinflammatory cytokines and chemokines (gamma interferon [IFN-γ], tumor necrosis factor alpha [TNF-α], and monocyte chemoattractant protein 1 [MCP-1]) in feces of obese children compared to those of lean ones. B. luti and B. wexlerae were also shown to exert an anti-inflammatory effect in peripheral blood mononuclear cell cultures in vitro, compared to non-obesity-associated species. We suggest that the depletion of B. luti and B. wexlerae species in the gut ecosystem may occur in cases of obesity and contribute to metabolic inflammation leading to insulin resistance., This study was supported by grant AGL2017-88801-P from the Ministry of Science, Innovation and Universities (MCIU; Spain) and the European Union’s Seventh Framework Program under grant agreement no. 613979 (MyNewGut). The contracts of A.B.-P. and E.M.G.D.P. were supported by the MyNewGut project. The FPI grant for I.L.-A. from MCIU (Spain) is fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial

  • Kjølbæk, Louise
  • Benítez-Páez, Alfonso
  • Gómez del Pulgar, Eva M.
  • Brahe, L.K.
  • Liebisch, G.
  • Matysik, S.
  • Rampelli, S.
  • Vermeiren, J.
  • Brigidi, P.
  • Larsen, L.H.
  • Astrup, A.
  • Sanz Herranz, Yolanda
Background & aims: Gut microbiota composition is linked to obesity and metabolic syndrome. The nutrients and doses required to modulate the gut microbiota towards beneficially influence components of the metabolic syndrome are unclear. This study aimed to investigate diet-induced effects on the gut microbiota and metabolic markers in overweight individuals with indices of the metabolic syndrome. Methods: A twelve-week randomized cross-over trial was conducted with two intervention periods separated by a washout period. The dietary intakes of interest were wheat bran extract, rich in arabinoxylan oligosaccharides (AXOS) (10.4 g/d AXOS) and polyunsaturated fatty acids (PUFA) (3.6 g/d n-3 PUFA). Dietary records, fecal and blood samples, as well as anthropometric data, were collected before and after intervention. Anthropometry and gastrointestinal symptoms were evaluated weekly. Gut microbiota composition was analyzed by massive sequencing of 16S ribosomal RNA gene V3V4 amplicons. Results: Twenty-seven participants completed the study (90%). Intake of AXOS induced an expected bifidogenic effect on gut microbiota (p < 0.01) and increased butyrate-producing bacterial species as well (p < 0.05). Beta-diversity analysis indicated that the structure of the gut microbiota only changed as a result of the AXOS intervention (Permanova = 1.90, p < 0.02) and no changes in metabolic markers were observed after any of the interventions. Conclusions: AXOS intake has a bifidogenic effect and also increases butyrate producers in the gut microbiota; even though this type of dietary fiber did not modulate lipid or glucose metabolic parameters related to metabolic syndrome. Four-week PUFA intake did not induce any notable effect on the gut microbiota composition or metabolic risk markers., This work was supported by the European Union's Seventh Framework Program [grant agreement no 613,979 (MyNewGut)]. Additional, funding to LK includes PhD grant from the Department of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen and support from the Innovative Medicines Initiative Joint Undertaking under EMIF [grant agreement n° 115,372], resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007–2013) and EFPIA companies' in kind contribution., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sex, Food, and the Gut Microbiota: Disparate Response to Caloric Restriction Diet with Fiber Supplementation in Women and Men

  • Benítez-Páez, Alfonso
  • Hess, A.L.
  • Krautbauer, S.
  • Liebisch, G.
  • Christensen, L.
  • Hjorth, M.F.
  • Larsen, T.M.
  • Sanz Herranz, Yolanda
This is the peer reviewed version of the following article: Benítez‐Páez, A., Hess, A. L., Krautbauer, S., Liebisch, G., Christensen, L., Hjorth, M. F., Larsen, T. M., Sanz, Y., Sex, Food, and the Gut Microbiota: Disparate Response to Caloric Restriction Diet with Fiber Supplementation in Women and Men. Mol. Nutr. Food Res. 2021, 65, 2000996, which has been published in final form at https://doi.org/10.1002/mnfr.202000996. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions., Scope: Dietary‐based strategies are regularly explored in controlled clinical trials to provide cost‐effective therapies to tackle obesity and its comorbidities. The article presents a complementary analysis based on a multivariate multi‐omics approach of a caloric restriction intervention (CRD) with fiber supplementation to unveil synergic effects on body weight control, lipid metabolism, and gut microbiota. Methods and results: The study explores fecal bile acids (BAs) and short‐chain fatty acids (SCFAs), plasma BAs, and fecal shotgun metagenomics on 80 overweight participants of a 12‐week caloric restriction clinical trial (−500 kcal day−1) randomly allocated into fiber (10 g day−1 inulin + 10 g day−1 resistant maltodextrin) or placebo (maltodextrin) supplementation groups. The multi‐omic data integration analysis uncovered the benefits of the fiber supplementation and/or the CRD (e.g., increase of Parabacteroides distasonis and fecal propionate), showing sex‐specific effects on either adiposity and fasting insulin; effects thought to be linked to changes of specific gut microbiota species, functional genes, and bacterially produced metabolites like SCFAs and secondary BAs. Conclusions: This study identifies diet‐microbe‐host interactions helping to design personalised interventions. It also suggests that sex perspective should be considered routinely in future studies on dietary interventions efficacy. All in all, the study uncovers that the dietary intervention is more beneficial for women than men., This study was fully funded by the European Commission 7th Framework Programme through the MyNewGut project (Grant agreement No. 613979)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacteroides uniformis CECT 7771 alleviates inflammation within the gut-adipose tissue axis involving TLR5 signaling in obese mice

  • Fabersani, Emanuel
  • Portune, Kevin
  • Campillo, Isabel
  • López-Almela, Inmaculada
  • Montserrat-de la Paz, Sergio
  • Romaní Pérez, Marina
  • Benítez-Páez, Alfonso
  • Sanz Herranz, Yolanda
This study investigated the immune mechanisms whereby administration of Bacteroides uniformis CECT 7771 reduces metabolic dysfunction in obesity. C57BL/6 adult male mice were fed a standard diet or a Western diet high in fat and fructose, supplemented or not with B. uniformis CECT 7771 for 14 weeks. B. uniformis CECT 7771 reduced body weight gain, plasma cholesterol, triglyceride, glucose, and leptin levels; and improved oral glucose tolerance in obese mice. Moreover, B. uniformis CECT 7771 modulated the gut microbiota and immune alterations associated with obesity, increasing Tregs and reducing B cells, total macrophages and the M1/M2 ratio in both the gut and epididymal adipose tissue (EAT) of obese mice. B. uniformis CECT 7771 also increased the concentration of the anti-inflammatory cytokine IL-10 in the gut, EAT and peripheral blood, and protective cytokines TSLP and IL-33, involved in Treg induction and type 2 innate lymphoid cells activation, in the EAT. It also restored the obesity–reduced TLR5 expression in the ileum and EAT. The findings indicate that the administration of a human intestinal bacterium with immunoregulatory properties on the intestinal mucosa helps reverse the immuno-metabolic dysfunction caused by a Western diet acting over the gut-adipose tissue axis., This work is supported by the European Union’s Seventh Framework Program under the Grant Agreement No 613979 (MyNewGut) and Grant AGL2017-88801-P from the Spanish Ministry of Science and Innovation (MICINN, Spain). The Santiago Grisolía scholarship (GRISOLIAP/2014/110) to E.F from Generalitat Valenciana and the FPI scholarship (BES-2015-073930) of I López-Almela and the PTA contract (PTA2013-8836-I) of I. Campillo from MICINN are fully acknowledged. The authors declare that there are no competing interests in this research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Holdemanella biformis improves glucose tolerance and regulates GLP-1 signaling in obese mice

  • Romaní Pérez, Marina
  • López-Almela, Inmaculada
  • Bullich Vilarrubias, Clara
  • Rueda-Ruzafa, Lola
  • Gómez del Pulgar, Eva M.
  • Benítez-Páez, Alfonso
  • Liebisch,Gerhard
  • Lamas, José Antonio
  • Sanz Herranz, Yolanda
Impaired glucose homeostasis in obesity is mitigated by enhancing the glucoregulatory actions of glucagon-like peptide 1 (GLP-1), and thus, strategies that improve GLP-1 sensitivity and secretion have therapeutic potential for the treatment of type 2 diabetes. This study shows that Holdemanella biformis, isolated from the feces of a metabolically healthy volunteer, ameliorates hyperglycemia, improves oral glucose tolerance and restores gluconeogenesis and insulin signaling in the liver of obese mice. These effects were associated with the ability of H. biformis to restore GLP-1 levels, enhancing GLP-1 neural signaling in the proximal and distal small intestine and GLP-1 sensitivity of vagal sensory neurons, and to modify the cecal abundance of unsaturated fatty acids and the bacterial species associated with metabolic health. Our findings overall suggest the potential use of H biformis in the management of type 2 diabetes in obesity to optimize the sensitivity and function of the GLP-1 system, through direct and indirect mechanisms., This study received funding from the European Union Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 797297 (M.R-P), from the European Union 7th Framework Program through the MyNewGut project (Grant agreement No. 613979) and from the Spanish Ministry of Science and Innovation (MICINN, Spain) (Grant AGL2017-88801-P). The FPI grant of I.L-A from the Ministry of Science and Innovation (MICINN; Spain) and the contract of C. B-V for promotion of youth employment in R+D+I from MICINN (Spain) are fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome

  • Hartstra, Annick V.
  • Schüppel, Valentina
  • Imangaliyev, Sultan
  • Schrantee, Anouk
  • Prodan, Andrei
  • Collard, Didier
  • Levin, Evgeni
  • Dallinga-Thie, Geesje
  • Ackermans, Mariette T.
  • Winkelmeijer, Maaike
  • Havik, Stefan R.
  • Metwaly, Amira
  • Lagkouvardos, Ilias
  • Nier, Anika
  • Bergheim, Ina
  • Heikenwalder, Mathias
  • Dunkel, Andreas
  • Nederveen, Aart J.
  • Liebisch, Gerhard
  • Mancano, Giulia
  • Claus, Sandrine P.
  • Benítez-Páez, Alfonso
  • la Fleur, Susanne E.
  • Bergman, Jacques J.
  • Gerdes, Victor
  • Sanz Herranz, Yolanda
  • Booij, Jan
  • Kemper, Elles
  • Groen, Albert K.
  • Serlie, Mireille J.
  • Haller, Dirk
  • Nieuwdorp, Max
Objective: Increasing evidence indicates that intestinal microbiota play a role in diverse metabolic processes via intestinal butyrate production. Human bariatric surgery data suggest that the gut-brain axis is also involved in this process, but the underlying mechanisms remain unknown. Methods: We compared the effect of fecal microbiota transfer (FMT) from post-Roux-en-Y gastric bypass (RYGB) donors vs oral butyrate supplementation on (123I-FP-CIT-determined) brain dopamine transporter (DAT) and serotonin transporter (SERT) binding as well as stable isotope-determined insulin sensitivity at baseline and after 4 weeks in 24 male and female treatment-naïve metabolic syndrome subjects. Plasma metabolites and fecal microbiota were also determined at these time points. Results: We observed an increase in brain DAT after donor FMT compared to oral butyrate that reduced this binding. However, no effect on body weight and insulin sensitivity was demonstrated after post-RYGB donor feces transfer in humans with metabolic syndrome. Increases in fecal levels of Bacteroides uniformis were significantly associated with an increase in DAT, whereas increases in Prevotella spp. showed an inverse association. Changes in the plasma metabolites glycine, betaine, methionine, and lysine (associated with the S-adenosylmethionine cycle) were also associated with altered striatal DAT expression. Conclusions: Although more and larger studies are needed, our data suggest a potential gut microbiota-driven modulation of brain dopamine and serotonin transporters in human subjects with obese metabolic syndrome. These data also suggest the presence of a gut-brain axis in humans that can be modulated., This study was funded by FP7-EU consortium MyNewGut grant agreement no. 613979 (to which A.V.H. was appointed). M. Nieuwdorp is supported by a ZONMW-VIDI grant 2013 (016.146.327)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in obese mice

  • López-Almela, Inmaculada
  • Romaní Pérez, Marina
  • Bullich Vilarrubias, Clara
  • Benítez-Páez, Alfonso
  • Gómez del Pulgar, Eva M.
  • Francés, R.
  • Liebisch, G.
  • Sanz Herranz, Yolanda
Gut microbiota represents a therapeutic target for obesity. We hypothesize that B. uniformis CECT 7771 combined with wheat bran extract (WBE), its preferred carbon source, may exert superior anti-obesity effects. We performed a 17-week intervention in diet-induced obese mice receiving either B. uniformis, WBE, or their combination to identify interactions and independent actions on metabolism and immunity. B. uniformis combined with WBE was the most effective intervention, curbing weight gain and adiposity, while exerting more modest effects separately. The combination restored insulin-dependent metabolic routes in fat and liver, although the bacterium was the primary driver for improving whole-body glucose disposal. Moreover, B. uniformis-combined with WBE caused the highest increases in butyrate and restored the proportion of induced intraepithelial lymphocytes and type-3 innate lymphoid cells in the intestinal epithelium. Thus, strengthening the first line of immune defense against unhealthy diets and associated dysbiosis in the intestine. This intervention also attenuated the altered IL22 signaling and liver inflammation. Our study shows opportunities for employing B. uniformis, combined with WBE, to aid in the treatment of obesity., This study was funded by the European Commission 7th Framework Programme through the MyNewGut project (Grant agreement No. 613979). The FPI scholarship from MCIU (Spain) to IL-A and the Erasmus+ (European commission) to CB-V are fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Complete Genome Sequence of Phascolarctobacterium faecium G 104, Isolated from the Stools of a Healthy Lean Donor

  • Rachek, Sadjia
  • Nikpoor, Naghmeh
  • Gómez del Pulgar, Eva M.
  • Gonzaga, Aitor
  • Sanz Herranz, Yolanda
  • Tompkins, Thomas A.
Phascolarctobacterium faecium is a strict anaerobe belonging to the Firmicutes phylum that is found abundantly in the human gastrointestinal tract. Here, we report the complete genome sequence of P. faecium G 104, a strain isolated from a fresh stool sample from a healthy lean donor., This work and the contract of E.M.G.D.P. were supported by the European Commission 7th Framework Program through the MyNewGut project (grant 613979). The contract of A.G. was supported by the European Commission H2020 Program through the EarlyCause project (grant 848158)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbial enterotypes beyond genus level: Bacteroides species as a predictive biomarker for weight change upon controlled intervention with arabinoxylan oligosaccharides in overweight subjects

  • Christensen, Lars
  • Sørensen, Claudia V.
  • Wøhlk, Frederikke U.
  • Kjølbæk, Louise
  • Astrup, Arne
  • Sanz Herranz, Yolanda
  • Hjorth, M.F.
  • Benítez-Páez, Alfonso
Recent studies indicate that microbial enterotypes may influence the beneficial effects of wholegrain enriched diets including bodyweight regulation. In a 4-week intervention trial, overweight subjects were randomized to consume either arabinoxylan-oligosaccharides (AXOS) (10.4 g/d) from wheat bran or polyunsaturated fatty acids (PUFA) (3.6 g/d). In the present study, we have stratified the subjects participating in the intervention (n = 29) according to the baseline Prevotella-to-Bacteroides (P/B) ratios through a post-hoc analysis and applied a linear mixed model analysis to identify the influence of this P/B ratio on the differences in weight changes in the intervention arms. Following AXOS consumption (n = 15), the high P/B group showed no bodyweight changes [−0.14 kg (95% CI: −0.67; 0.38, p = .59)], while the low P/B group gained 0.65 kg (95% CI: 0.16; 1.14, p = .009). Consequently, a difference of −0.79 kg was found between P/B groups (95% CI: −1.51; −0.08, p = .030). No differences were found between P/B groups following PUFA consumption (0.61 kg, 95% CI: −0.13; 1.35, p = .10). Among the Bacteroides species, B. cellulosilyticus relative abundance exhibited the highest positive rank correlation (Kendall’s tau = 0.51, FDR p = .070) with 4-week weight change on AXOS, and such association was further supported by using supervised classification methods (Random Forest). We outlined several carbohydrate-active enzyme (CAZy) genes involved in xylan-binding and degradation to be enriched in B. cellulosilyticus genomes, as well as multiple accessory genes, suggesting a supreme AXOS-derived glycan scavenging role of such species. This post-hoc analysis, ensuring species and strain demarcation at the human gut microbiota, permitted to uncover the predictive role of Bacteroides species over P/B enterotype in weight gain during a fiber-based intervention. The results of this pilot trial pave the way for future assessments on fiber fermentation outputs from Bacteroides species affecting lipid metabolism in the host and with direct impact on adiposity, thus helping to design personalized interventions., The European Commission 7th Framework Programme through the MyNewGut project (Grant agreement No. 613979) supported this study by sharing genetic and clinical data used in here. The Miguel Servet CP19/00132 grant from the Spanish Institute of Health Carlos III (ISCIII) to ABP is fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multi-omics gut microbiome signatures in obese women: role of diet and uncontrolled eating behavior

  • Barone, Monica
  • Garelli, Silvia
  • Rampelli, Simone
  • Agostini, Alessandro
  • Matysik, Silke
  • D'Amico, Federica
  • Krautbauer, Sabrina
  • Mazza, Roberta
  • Salituro, Nicola
  • Fanelli, Flaminia
  • Iozzo, Patricia
  • Sanz Herranz, Yolanda
  • Candela, Marco
  • Brigidi, Patrizia
  • Pagotto, Uberto
  • Turroni, Silvia
Obesity and related co-morbidities represent a major health challenge nowadays, with a rapidly increasing incidence worldwide. The gut microbiome has recently emerged as a key modifier of human health that can affect the development and progression of obesity, largely due to its involvement in the regulation of food intake and metabolism. However, there are still few studies that have in-depth explored the functionality of the human gut microbiome in obesity and even fewer that have examined its relationship to eating behaviors., This study was fully funded by the European Commission 7th Framework Programme through the MyNewGut project (Grant agreement No. 613979) and the NeuroFAST project (grant agreement no. 245009)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multi-locus and long amplicon sequencing approach to study microbial diversity at species level using the MinION™ portable nanopore sequencer

  • Benítez-Páez, Alfonso
  • Sanz Herranz, Yolanda
The miniaturized and portable DNA sequencer MinION™ has demonstrated great potential in different analyses such as genome-wide sequencing, pathogen outbreak detection and surveillance, human genome variability, and microbial diversity. In this study, we tested the ability of the MinION™ platform to perform long amplicon sequencing in order to design new approaches to study microbial diversity using a multi-locus approach. After compiling a robust database by parsing and extracting the rrn bacterial region from more than 67000 complete or draft bacterial genomes, we demonstrated that the data obtained during sequencing of the long amplicon in the MinION™ device using R9 and R9.4 chemistries were sufficient to study 2 mock microbial communities in a multiplex manner and to almost completely reconstruct the microbial diversity contained in the HM782D and D6305 mock communities. Although nanopore-based sequencing produces reads with lower per-base accuracy compared with other platforms, we presented a novel approach consisting of multi-locus and long amplicon sequencing using the MinION™ MkIb DNA sequencer and R9 and R9.4 chemistries that help to overcome the main disadvantage of this portable sequencing platform. Furthermore, the nanopore sequencing library, constructed with the last releases of pore chemistry (R9.4) and sequencing kit (SQK-LSK108), permitted the retrieval of the higher level of 1D read accuracy sufficient to characterize the microbial species present in each mock community analysed. Improvements in nanopore chemistry, such as minimizing base-calling errors and new library protocols able to produce rapid 1D libraries, will provide more reliable information in the near future. Such data will be useful for more comprehensive and faster specific detection of microbial species and strains in complex ecosystems., This work and the contract to A.B.P. were supported by the European Union's Seventh Framework Program under the grant agreement number 613979 (MyNewGut)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bosom Buddies: The Symbiotic Relationship Between Infants and Bifidobacterium longum ssp. longum and ssp. infantis. Genetic and Probiotic Features

  • Arboleya, Silvia
  • Stanton, Catherine
  • Ryan, C. Anthony
  • Dempsey, Eugene
  • Ross, Paul R.
The intestinal microbiota is a complex community that plays an important role in human health from the initial steps of its establishment. Its microbial composition has been suggested to result from selective pressures imposed by the host and is modulated by competition among its members. Bifidobacterium longum is one of the most abundant species of the Bifidobacterium genus in the gut microbiota of healthy breast-fed infants and adults. The recent advancements of ‘omics techniques have facilitated the genetic and functional studies of different gut microbiota members. They have revealed the complex genetic pathways used to metabolize different compounds that likely contribute to the competitiveness and persistence of B. longum in the colon. The discovery of a genomic island in B. longum ssp. infantis that encodes specific enzymes for the metabolism of human milk oligosaccharides suggests a specific ecological adaptation. Moreover, B. longum is widely used as probiotic, and beneficial effects in infant health have been reported in several studies., The authors and this work were supported by the Science Foundation Ireland (SFI)-funded APC Microbiome Institute; by SFI (Infant 12/RC/2272); by Department of Agriculture Food and Marine (DAFM)-funded INFANTMET (Ref. No. 10FDairy) and ToddlerFood (Ref. No. 14F821) projects; and by European Union's Seventh Framework Program (EUFP7)-funded MyNewGut project (Ref. No. 613979)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut Bifidobacteria Populations in Human Health and Aging

  • Arboleya, Silvia
  • Watkins, Claire
  • Stanton, Catherine
  • Ross, R. Paul
The intestinal microbiota has increasingly been shown to have a vital role in various aspects of human health. Indeed, several studies have linked alterations in the gut microbiota with the development of different diseases. Among the vast gut bacterial community, Bifidobacterium is a genus which dominates the intestine of healthy breast-fed infants whereas in adulthood the levels are lower but relatively stable. The presence of different species of bifidobacteria changes with age, from childhood to old age. Bifidobacterium longum, B. breve, and B. bifidum are generally dominant in infants, whereas B. catenulatum, B. adolescentis and, as well as B. longum are more prevalent in adults. Increasingly, evidence is accumulating which shows beneficial effects of supplementation with bifidobacteria for the improvement of human health conditions ranging from protection against infection to different extra- and intra-intestinal positive effects. Moreover, bifidobacteria have been associated with the production of a number of potentially health promoting metabolites including short chain fatty acids, conjugated linoleic acid and bacteriocins. The aim of this mini-review is to describe the bifidobacteria compositional changes associated with different stages in life, highlighting their beneficial role, as well as their presence or absence in many disease states., This research was supported by the Science Foundation Ireland (SFI)-funded APC Microbiome Institute; by Department of Agriculture Food and Marine (DAFM)-funded INFANTMET (Ref. No. 10FDairy) and ToddlerFood (Ref. No. 14F821) projects; and by European Union’s Seventh Framework Program (EUFP7)-funded MyNewGut project (Ref. No. 613979)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacteroides uniformis CECT 7771 requires adaptive immunity to improve glucose tolerance but not to prevent body weight gain in diet-induced obese mice

  • Romaní Pérez, Marina
  • López Almela, Inmaculada
  • Bullich Vilarrubias, Clara
  • Evtoski, Zoran
  • Benítez-Páez, Alfonso
  • Sanz Herranz, Yolanda
Background: The metabolic disturbances of obesity can be mitigated by strategies modulating the gut microbiota. In this study, we sought to identify whether innate or adaptive immunity mediates the beneficial metabolic effects of the human intestinal bacterium Bacteroides uniformis CECT 7771 in obesity. Methods: We evaluated the effects of orally administered B. uniformis on energy homeostasis, intestinal immunity, hormone levels, and gut microbiota in wild-type and Rag1-deficient mice with diet-induced obesity. We also assessed whether B. uniformis needed to be viable to exert its beneficial effects in obesity and to directly induce immunoregulatory effects. Results: The administration of B. uniformis to obese mice improved glucose tolerance and insulin secretion, restored the caloric intake suppression after an oral glucose challenge, and reduced hyperglycemia. The pre- and post-prandial glucose-related benefits were associated with restoration of the anti-inflammatory tone mediated by type 2 macrophages and regulatory T cells (Tregs) in the lamina propria of the small intestine. Contrastingly, B. uniformis administration failed to improve glucose tolerance in obese Rag1-/- mice, but prevented the increased body weight gain and adiposity. Overall, the beneficial effects seemed to be independent of enteroendocrine effects and of major changes in gut microbiota composition. B. uniformis directly induced Tregs generation from naïve CD4+ T cells in vitro and was not required to be viable to improve glucose homeostasis but its viability was necessary to prevent body weight gain in diet-induced obese wild-type mice. Conclusions: Here we demonstrate that B. uniformis modulates the energy homeostasis in diet-induced obese mice through different mechanisms. The bacterium improves oral glucose tolerance by adaptive immunity-dependent mechanisms that do not require cell viability and prevents body weight gain by adaptive immunity-independent mechanisms which require cell viability., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This study received funding from the European Union 7th Framework Program through the MyNewGut project (Grant agreement No. 613979) and from the Spanish Ministry of Science and Innovation (grant PID2020-119536RB-I00). The FPI contract of I.L.-A. from the Ministry of Science and Innovation (Spain) and the contract of C. B-V for promotion of youth employment in R+D+I from Ministry of Science and Innovation (Spain) are fully acknowledged., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota DPP4-like enzymes are increased in type-2 diabetes and contribute to incretin inactivation

  • Olivares, Marta
  • Hernández Calderón, Paula
  • Cárdenas Brito, Sonia
  • Liébana García, Rebeca
  • Sanz Herranz, Yolanda
  • Benítez-Páez, Alfonso
Background:The gut microbiota controls broad aspects of human metabolism and feeding behavior, but the basis for this control remains largely unclear. Given the key role of human dipeptidyl peptidase 4 (DPP4) in host metabolism, we investigate whether microbiota DPP4-like counterparts perform the same function. Results: We identify novel functional homologs of human DPP4 in several bacterial species inhabiting the human gut, and specific associations between Parabacteroides and Porphyromonas DPP4-like genes and type 2 diabetes (T2D). We also find that the DPP4-like enzyme from the gut symbiont Parabacteroides merdae mimics the proteolytic activity of the human enzyme on peptide YY, neuropeptide Y, gastric inhibitory polypeptide (GIP), and glucagon-like peptide 1 (GLP-1) hormones in vitro. Importantly, administration of E. coli overexpressing the P. merdae DPP4-like enzyme to lipopolysaccharide-treated mice with impaired gut barrier function reduces active GIP and GLP-1 levels, which is attributed to increased DPP4 activity in the portal circulation and the cecal content. Finally, we observe that linagliptin, saxagliptin, sitagliptin, and vildagliptin, antidiabetic drugs with DPP4 inhibitory activity, differentially inhibit the activity of the DPP4-like enzyme from P. merdae. Conclusions: Our findings confirm that proteolytic enzymes produced by the gut microbiota are likely to contribute to the glucose metabolic dysfunction that underlies T2D by inactivating incretins, which might inspire the development of improved antidiabetic therapies., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The authors acknowledge the following funding bodies that provided support for this study: European Commission 7th Framework Program through the MyNewGut project (Grant agreement No. 613979) and the Spanish Ministry of Science and Innovation (MICINN) (grant PID2020-119536RB-I00) to YS; Institute of Health Carlos III (ISCIII) via CP19/00132 grant to AB-P with funds from the European Social Fund (ESF/FSE), CIPF Predoctoral Training Fellowships 2022 funded by JANSSEN-CILAG—supporting the contract of PH-C, CIPF core funding for the contract of SC-B; Early Career Grant from the Society for Endocrinology award to MO. Spanish Government MCIN/AEI for the Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/ MCIN/AEI / https://doi.org/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut commensal Phascolarctobacterium faecium retunes innate immunity to mitigate obesity and metabolic disease in mice

  • Liébana García, Rebeca
  • López Almela, Inmaculada
  • Olivares, Marta
  • Romaní Pérez, Marina
  • Manghi, Paolo
  • Torres Mayo, Alba
  • Tolosa Enguís, Verónica
  • Flor Duro, Alejandra
  • Bullich Vilarrubias, Clara
  • Rubio, Teresa
  • Rossini, Valerio
  • Segata, Nicola
  • Sanz, Yolanda
The gut microbiota may protect against obesity and chronic metabolic conditions by regulating the immune response to dietary triggers. Yet the specific bacteria that control the overactivation of the immune system in obesity and their mode of action remain largely unknown. Here we surveyed 7,569 human metagenomes and observed an association between the gut symbiont Phascolarctobacterium faecium and non-obese adults regardless of nationality, sex or age. In a mouse model of diet-induced obesity, we confirmed the specificity of P. faecium DSM 32890 anti-obesogenic properties compared with other species of the same genus. P. faecium reversed the inflammatory phenotype associated with obesity. Specifically, P. faecium promoted polarization of alternatively activated macrophages (M2), which reversed the obesity-induced increase in gut-resident type 1 innate lymphoid cells. This resulted in mitigation of glucose intolerance, adiposity and body weight gain irrespective of treatment with live or pasteurized bacteria. The metabolic benefits were independent of the adaptive immune system, but they were abolished by an inhibitor of M2 polarization in mice. P. faecium directly promoted M2-macrophage polarization through TLR2 signalling and these effects seemed to be independent of gut microbiota changes. Overall, we identify a previously undescribed gut commensal bacterium that could help mitigate obesity and metabolic comorbidities by retuning the innate immune response to hypercaloric diets., This study was funded by the European Union 7th Framework Program through the MyNewGut project (Grant Agreement No. 613979) and the Spanish Ministry of Science, Innovation and Universities (MCIU; grant PID2020-119536RB-I00). The FPU and FPI grant contracts from the MCIU to R.L.-G. (FPU18/02026) and I.L.-A. (BES-2015-073930) and a Marie Sklodowska-Curie Actions (MSCA-IF) contract to M.O. (‘MicroILCs’, GA: 8905454) and M.R.-P. (‘miVaO’, GA: 797297) are acknowledged. The grant of accreditation as a Severo Ochoa Center of Excellence from MCIN/AEI (CEX2021- 001189-S/ MCIN/AEI / 10.13039/501100011033) is also acknowledged., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Janus Face of Cereals: Wheat-Derived Prebiotics Counteract the Detrimental Effect of Gluten on Metabolic Homeostasis in Mice Fed a High-Fat/High-Sucrose Diet

  • Olivares, Marta
  • Rodriguez, Julie
  • Pötgens, Sarah A.
  • Neyrinck, Audrey M.
  • Cani, Patrice D.
  • Bindels, Laure B.
  • Delzenne, Nathalie M.
Cereals are important sources of carbohydrates, but also contain nutrients that could impact adiposity. The contribution of gluten to obesity and the effects of prebiotics-arabinoxylo-oligosaccharides (AXOS) and fructo-oligosaccharides (FOS)-that can be extracted from gluten-containing cereals are analyzed., This work was supported by EU grant 613979 (MyNewGut). M.O. is a beneficiary of a “MOVE-IN Louvain” Incoming Post-doctoral Fellowship co-funded by the Marie Curie Actions of the European Commission. P.D.C. is senior research associate of the FRS-FNRS (Fonds de la Recherche Scientifique) and is supported by the FRFS-WELBIO (WELBIO-CR-2017-02) and the Funds Baillet Latour (Grant for Medical Research 2015). N.M.D. is a recipient of grants from Wallonia (FOOD4GUT project; FiberTAG project from European Joint Programming Initiative “A Healthy Diet for a Healthy Life”) and from Belgium National Scientific Research Fund (FRS-FNRS)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disrupted gut microbiome networks and unhealthy behaviors predict metabolic dysfunction in children and adolescents in the long term

  • Turroni, Silvia
  • Günther, Kathrin
  • D'Amico, Federica
  • Veidebaum, Toomas
  • Kourides, Yiannis
  • Molnár, Dénes
  • Lissner, Lauren
  • Foraita, Ronja
  • Barone, Monica
  • Mora-Martínez, Carlos
  • Sanz Herranz, Yolanda
  • Fraterman, Arno
  • Wolters, Maike
  • Brigidi, Patrizia
  • Candela, Marco
  • Ahrens, Wolfgang
  • Rampelli, Simone
We recently showed that the individual gut microbiome (GM) configuration in children and adolescents, together with long-term dietary habits, can predict the development of obesity. Here, we expanded our previous cohort to include 218 individuals and used 16S rRNA amplicon sequencing, shotgun metatranscriptomics, and a network approach to analyze fecal samples collected at a baseline survey and after a 4-year follow-up, investigating associations with health status, dietary intake, and other health-related behaviors. Our results showed that an unbalanced GM profile in children/adolescents, with few represented species, poor connectivity, and low transcriptional activity (especially in relation to molecular effectors that positively influence gut and immune health), combined with unhealthy behaviors (i.e., low-fiber diet and reduced physical activity), may favor the onset of obesity. This knowledge may pave the way for the development of adjunct GM-based precision intervention strategies aimed at rewiring microbial networks to promote long-term health., This study has been funded by the FP7-EU MyNewGut grant agreement No. 613979, and the “Severo Ochoa” grant of National Agency for Research (AEI) - Spanish Ministry of Science and Innovation (Ref. CEX2021-001189-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phascolarctobacterium faecium reduces food intake via PYY signaling, contributing to the mitigation of body weight gain in diet-induced obese mice

  • Bullich Vilarrubias, Clara
  • Romaní Pérez, Marina
  • López-Almela, Inmaculada
  • Pomares Díaz, Carlos
  • Basili Franzin, Silvia
  • Esposito, Giuseppe
  • Benítez-Páez, Alfonso
  • Tolosa Enguís, Verónica
  • Sanz Herranz, Yolanda
Excess energy intake contributes to adiposity in obesity. We investigated whether the human intestinal bacterium Phascolarctobacterium faecium could prevent obesity via enteroendocrine pathways in a mouse model of diet-induced obesity (DIO). Daily administration of P. faecium (2 × 109 cells/mouse) reduced food intake through the early overproduction of the satiety hormone peptide YY (PYY) compared to untreated DIO mice. Moreover, P. faecium increased the intestinal levels of branched-chain amino acids, which, in turn, stimulated PYY secretion in neuroendocrine cell cultures and also modified gut microbiota composition. A pair-feeding study demonstrated that the anorexigenic effect of P. faecium contributes to its effects in attenuating body weight gain in DIO mice, but that other mechanisms are also involved in its metabolic benefits. Specifically, P. faecium accelerated gut transit and serum lipid clearance, thereby limiting adiposity independently of food intake. This study identifies the mode of action of a human intestinal bacterium recently linked to obesity protection, providing valuable insights into host-microbe interactions governing body weight., This study has been funded by the European Union 7th Framework Program through MyNewGut project (Grant agreement No. 613979), the Spanish Ministry of Science, Innovation and Universities (MCIU; grants PID2020-119536RB-I00, PID2023-150693OB-I00) and the European Commission – NextGenerationEU, through CSIC Interdisciplinary Thematic Platform (PTI+) NEURO-AGINGl+. (PTI-NEURO-AGING+)”. (EU (European Union)), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE)

  • Berglund, Staffan K.
  • García Valdés, Luz
  • Torres Espinola, Francisco José
  • Segura, Mª Teresa
  • Martínez Zaldívar, Cristina
  • Aguilar María, J.
  • Agil, Ahmad
  • Lorente Jose, A.
  • Florido, Jesús
  • Padilla, Carmen
  • Altmäe, Signe
  • Marcos, Ascensión
  • López Sabater, María del Carmen
  • Campoy Folgoso, Cristina
  • PREOBE Team
Abstract Background: Maternal overweight, obesity, and gestational diabetes (GD) have been negatively associated with offspring development. Further knowledge regarding metabolic and nutritional alterations in these mother and their offspring are warranted. Methods: In an observational cohort study we included 331 pregnant women from Granada, Spain. The mothers were categorized into four groups according to BMI and their GD status; overweight (n:56), obese (n:64), GD (n:79), and healthy normal weight controls (n:132). We assessed maternal growth and nutritional biomarkers at 24 weeks (n = 269), 34 weeks (n = 310) and at delivery (n = 310) and the perinatal characteristics including cord blood biomarkers. Results: Obese and GD mothers had significantly lower weight gain during pregnancy and infant birth weight, waist circumference, and placental weight were higher in the obese group, including a significantly increased prevalence of macrosomia. Except for differences in markers of glucose metabolism (glucose, HbA1c, insulin and uric acid) we found at some measures that overweight and/or obese mothers had lower levels of transferrin saturation, hemoglobin, Vitamin B12 and folate and higher levels of C-reactive protein, erythrocyte sedimentation rate, ferritin, and cortisol. GD mothers had similar differences in hemoglobin and C-reactive protein but higher levels of folate. The latter was seen also in cord blood. Conclusions: We identified several metabolic alterations in overweight, obese and GD mothers compared to controls. Together with the observed differences in infant anthropometrics, these may be important biomarkers in future research regarding the programming of health and disease in children. Trial registration: The trial was registered at clinicaltrials.gov, identifier (NCT01634464). Keywords: Pregnancy, Maternal overweight, Maternal obesity, Gestational diabetes, Offspring, Fetal nutrition, Early programming, Vitamin B12, Folate, Iron status, Glucose metabolism